Siirry pääsisältöön
Käyttämääsi selainta ei enää tueta – lue lisää.

Novo Nordisk B

Novo Nordisk B

311,05DKK
−2,39% (−7,60)
Päätöskurssi
Ylin314,95
Alin307,85
Vaihto
1 605,3 MDKK
311,05DKK
−2,39% (−7,60)
Päätöskurssi
Ylin314,95
Alin307,85
Vaihto
1 605,3 MDKK

Novo Nordisk B

Novo Nordisk B

311,05DKK
−2,39% (−7,60)
Päätöskurssi
Ylin314,95
Alin307,85
Vaihto
1 605,3 MDKK
311,05DKK
−2,39% (−7,60)
Päätöskurssi
Ylin314,95
Alin307,85
Vaihto
1 605,3 MDKK

Novo Nordisk B

Novo Nordisk B

311,05DKK
−2,39% (−7,60)
Päätöskurssi
Ylin314,95
Alin307,85
Vaihto
1 605,3 MDKK
311,05DKK
−2,39% (−7,60)
Päätöskurssi
Ylin314,95
Alin307,85
Vaihto
1 605,3 MDKK
Q3-osavuosiraportti
10 päivää sitten1 t 9 min
3,75 DKK/osake
Viimeisin osinko
3,66 %Tuotto/v

Tarjoustasot

DenmarkNasdaq Copenhagen
Määrä
Osto
1 871 502
Myynti
Määrä
1 794 608

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
43--
2 660--
109--
30--
61--
Ylin
314,95
VWAP
310,81
Alin
307,85
VaihtoMäärä
1 605,3 5 165 142
VWAP
310,81
Ylin
314,95
Alin
307,85
VaihtoMäärä
1 605,3 5 165 142

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Seuraava tapahtuma
2025 Q4-osavuosiraportti
4.2.2026
Menneet tapahtumat
2025 Ylimääräinen yhtiökokous14.11.
2025 Q3-osavuosiraportti5.11.
2025 Q2-osavuosiraportti7.8.
2025 Q2-osavuosiraportti6.8.
2025 Q1-osavuosiraportti7.5.
Datan lähde: Millistream, Quartr

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 20 min sitten · Muokattu
    ·
    20 min sitten · Muokattu
    ·
    Lars Rebien Sørensen lifts the veil on a possible new strategy for the pharmaceutical giant. Here, he opened up the possibility that the pharmaceutical giant's popular GLP-1 medicine – including Wegovy and Ozempic – might in the future be sold as over-the-counter medicine. https://ekstrabladet.dk/penge/uden-recept-novo-konge-antyder-ny-kurs/11009971?utm_term=Autofeed&utm_medium=Social&utm_source=Facebook&fbclid=IwY2xjawOFRGxleHRuA2FlbQIxMABicmlkETAzRHhNQVZKWVg5Mmc0SE92c3J0YwZhcHBfaWQQMjIyMDM5MTc4ODIwMDg5MghjYWxsc2l0ZQEyAAEezBHDc0aZRfqSK-a_sMraT23t7nG5hEpmHkTrbbAglCZQt1XsINxZETG6pE0_aem_llU_Vg9ExjzAutNlb51DHw#Echobox=1763201526
  • 2 t sitten · Muokattu
    2 t sitten · Muokattu
    Can you feel it? Next week is going to be great! FOMO kicks in after this week's market pullback. People stock up on weight loss drugs to handle the Christmas feasts. Expectations of a pill approval is in the air (tempered by a bit of fears of FDA waiting for Eli to catch up). No explosions with no big good news but a nice green reinvestment week slowly seeing us try to break necklines. Have a nice weekend everyone!
  • 7 t sitten · Muokattu
    ·
    7 t sitten · Muokattu
    ·
    The stock is either consolidating or distributing around two important support lines. One is a multi-year trend back to 2017 and there is a support from 2021 before it took off. I want to see the stock break 314 before I can say that the damage is rectified after it has completed phase 4 in its cycle, and we go into phase 1 again. It is not entirely decided yet, we still don't know if phase 4 is finished, even though I personally believe it. It is not done overnight if anyone expects that. There is a lot of imbalance created in such a fall and it is completely normal to see a longer phase 1 form. Months are not uncommon.
    4 t sitten
    ·
    4 t sitten
    ·
    ....and Mars shall have an angle of 14.7 gr, to Jupiter..... Good weekend
    2 min sitten · Muokattu
    ·
    2 min sitten · Muokattu
    ·
    Typical statement, but I will answer briefly. TA can be used for a lot. I use it in short-term trading, to identify support, resistance, which indicates where buyers and sellers are. Impossible to trade without insight there. For investing, I use TA in a completely different way. I can use TA to identify the personality of the stock. For example, does it tend to hold 50 SMA, 200 SMA, and I can use that to get good entries. That can save me a ton of money compared to buying blindly. I also use TA to identify trends, where I use weekly and monthly trend indicators to identify bottoms and tops. Igjebflr good entries and exits. You don't use TA to identify value. That is fundamental analysis, which one should also do. One does fundamental analysis, macro analysis to identify the big picture. Then thinking to find entries. All stocks have personality, they very, very often repeat things they have done before in similar events. It's about identifying what history says about future behavior. And it works. You don't scan the market every second for that, you use long trends, weekly, monthly etc. The fact is that 80% of all market movements you see come from trading. That means that 80% of everyone is sitting and looking at exactly the same as you. That means a very high probability that something happens on these lines, as you call it. As long as you don't have or won't get into this, you will never understand it. Plain and simple. We others userservice for to create an Edge, to have a much higher degree of probability for an investment to be made in the right place. December 2021. I used long trends, and identified the fall in 2022, I did the same at the end of 2022 to identify that the trend was about to turn. That gave me unique opportunities. I took off a lot before 22, and put everything in at the end of the year ++++. I avoided sitting with dummy positions and seeing my stocks dumped 60/70%. You just have to calculate it if you avoided it on a million. Or five. Incredible that one can criticize something one knows nothing about is my message!!!! All large investors, institutions, banks' trading desks, hedge funds etc use this to gain an edge over the masses of small investors. I don't think they would have had thousands of traders working for fun. We start with fundamental and macro analysis to identify if a company is a good investment, then technical to find the best entry and exit. It all belongs together.
  • 13 t sitten
    ·
    13 t sitten
    ·
    It's a paradox that so many hate the NOVO stock due to self-ignorance, where one bought at 20x FPE and thought the stock was cheap. Also, when the price falls by 1/3, it was then actually "super expensive" and when FPE reaches 10 and dividend is around 5%, then it is again cheap, just much cheaper than before. Even if you made a good long-term investment that you are no longer as optimistic about, the "case" is relatively (EX competition and market development) the same even if the price is not. If you thought 500 DKK was a good price, then 350 is a fantastic price! The people here just lack some balls to stick with it or worse, they have FOMO because they are not surfing the AI wave, hahaha.
    32 min sitten
    ·
    32 min sitten
    ·
    There are/were many Novo shareholders who could just buy the stock and watch it rise. Thus, they could say they were “successful” investors. Unfortunately, they have had a rude awakening, and they face a dilemma: sell or hold. With a loss of 58% in the last year, it will take a long time to recover the loss. If it's even possible. At the same time, these same investors can look at the Eli Lilly stock with an increase of +38% in the last year. Or like my colleagues who use Rheinmetal as savings (they are a bit annoying to listen to🤣). It is immediately difficult to see what would make the Novo stock rise. There is uncertainty about management, future earnings, market shares, a thin short-term pipeline, U.S. sales, etc. Which is why many choose other growth stocks.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Uutiset ja analyysit

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Tuotteita joiden kohde-etuutena tämä arvopaperi

Q3-osavuosiraportti
10 päivää sitten1 t 9 min
3,75 DKK/osake
Viimeisin osinko
3,66 %Tuotto/v

Uutiset ja analyysit

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 20 min sitten · Muokattu
    ·
    20 min sitten · Muokattu
    ·
    Lars Rebien Sørensen lifts the veil on a possible new strategy for the pharmaceutical giant. Here, he opened up the possibility that the pharmaceutical giant's popular GLP-1 medicine – including Wegovy and Ozempic – might in the future be sold as over-the-counter medicine. https://ekstrabladet.dk/penge/uden-recept-novo-konge-antyder-ny-kurs/11009971?utm_term=Autofeed&utm_medium=Social&utm_source=Facebook&fbclid=IwY2xjawOFRGxleHRuA2FlbQIxMABicmlkETAzRHhNQVZKWVg5Mmc0SE92c3J0YwZhcHBfaWQQMjIyMDM5MTc4ODIwMDg5MghjYWxsc2l0ZQEyAAEezBHDc0aZRfqSK-a_sMraT23t7nG5hEpmHkTrbbAglCZQt1XsINxZETG6pE0_aem_llU_Vg9ExjzAutNlb51DHw#Echobox=1763201526
  • 2 t sitten · Muokattu
    2 t sitten · Muokattu
    Can you feel it? Next week is going to be great! FOMO kicks in after this week's market pullback. People stock up on weight loss drugs to handle the Christmas feasts. Expectations of a pill approval is in the air (tempered by a bit of fears of FDA waiting for Eli to catch up). No explosions with no big good news but a nice green reinvestment week slowly seeing us try to break necklines. Have a nice weekend everyone!
  • 7 t sitten · Muokattu
    ·
    7 t sitten · Muokattu
    ·
    The stock is either consolidating or distributing around two important support lines. One is a multi-year trend back to 2017 and there is a support from 2021 before it took off. I want to see the stock break 314 before I can say that the damage is rectified after it has completed phase 4 in its cycle, and we go into phase 1 again. It is not entirely decided yet, we still don't know if phase 4 is finished, even though I personally believe it. It is not done overnight if anyone expects that. There is a lot of imbalance created in such a fall and it is completely normal to see a longer phase 1 form. Months are not uncommon.
    4 t sitten
    ·
    4 t sitten
    ·
    ....and Mars shall have an angle of 14.7 gr, to Jupiter..... Good weekend
    2 min sitten · Muokattu
    ·
    2 min sitten · Muokattu
    ·
    Typical statement, but I will answer briefly. TA can be used for a lot. I use it in short-term trading, to identify support, resistance, which indicates where buyers and sellers are. Impossible to trade without insight there. For investing, I use TA in a completely different way. I can use TA to identify the personality of the stock. For example, does it tend to hold 50 SMA, 200 SMA, and I can use that to get good entries. That can save me a ton of money compared to buying blindly. I also use TA to identify trends, where I use weekly and monthly trend indicators to identify bottoms and tops. Igjebflr good entries and exits. You don't use TA to identify value. That is fundamental analysis, which one should also do. One does fundamental analysis, macro analysis to identify the big picture. Then thinking to find entries. All stocks have personality, they very, very often repeat things they have done before in similar events. It's about identifying what history says about future behavior. And it works. You don't scan the market every second for that, you use long trends, weekly, monthly etc. The fact is that 80% of all market movements you see come from trading. That means that 80% of everyone is sitting and looking at exactly the same as you. That means a very high probability that something happens on these lines, as you call it. As long as you don't have or won't get into this, you will never understand it. Plain and simple. We others userservice for to create an Edge, to have a much higher degree of probability for an investment to be made in the right place. December 2021. I used long trends, and identified the fall in 2022, I did the same at the end of 2022 to identify that the trend was about to turn. That gave me unique opportunities. I took off a lot before 22, and put everything in at the end of the year ++++. I avoided sitting with dummy positions and seeing my stocks dumped 60/70%. You just have to calculate it if you avoided it on a million. Or five. Incredible that one can criticize something one knows nothing about is my message!!!! All large investors, institutions, banks' trading desks, hedge funds etc use this to gain an edge over the masses of small investors. I don't think they would have had thousands of traders working for fun. We start with fundamental and macro analysis to identify if a company is a good investment, then technical to find the best entry and exit. It all belongs together.
  • 13 t sitten
    ·
    13 t sitten
    ·
    It's a paradox that so many hate the NOVO stock due to self-ignorance, where one bought at 20x FPE and thought the stock was cheap. Also, when the price falls by 1/3, it was then actually "super expensive" and when FPE reaches 10 and dividend is around 5%, then it is again cheap, just much cheaper than before. Even if you made a good long-term investment that you are no longer as optimistic about, the "case" is relatively (EX competition and market development) the same even if the price is not. If you thought 500 DKK was a good price, then 350 is a fantastic price! The people here just lack some balls to stick with it or worse, they have FOMO because they are not surfing the AI wave, hahaha.
    32 min sitten
    ·
    32 min sitten
    ·
    There are/were many Novo shareholders who could just buy the stock and watch it rise. Thus, they could say they were “successful” investors. Unfortunately, they have had a rude awakening, and they face a dilemma: sell or hold. With a loss of 58% in the last year, it will take a long time to recover the loss. If it's even possible. At the same time, these same investors can look at the Eli Lilly stock with an increase of +38% in the last year. Or like my colleagues who use Rheinmetal as savings (they are a bit annoying to listen to🤣). It is immediately difficult to see what would make the Novo stock rise. There is uncertainty about management, future earnings, market shares, a thin short-term pipeline, U.S. sales, etc. Which is why many choose other growth stocks.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

DenmarkNasdaq Copenhagen
Määrä
Osto
1 871 502
Myynti
Määrä
1 794 608

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
43--
2 660--
109--
30--
61--
Ylin
314,95
VWAP
310,81
Alin
307,85
VaihtoMäärä
1 605,3 5 165 142
VWAP
310,81
Ylin
314,95
Alin
307,85
VaihtoMäärä
1 605,3 5 165 142

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt

Yhtiötapahtumat

Seuraava tapahtuma
2025 Q4-osavuosiraportti
4.2.2026
Menneet tapahtumat
2025 Ylimääräinen yhtiökokous14.11.
2025 Q3-osavuosiraportti5.11.
2025 Q2-osavuosiraportti7.8.
2025 Q2-osavuosiraportti6.8.
2025 Q1-osavuosiraportti7.5.
Datan lähde: Millistream, Quartr

Tuotteita joiden kohde-etuutena tämä arvopaperi

Q3-osavuosiraportti
10 päivää sitten1 t 9 min

Uutiset ja analyysit

Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.

Yhtiötapahtumat

Seuraava tapahtuma
2025 Q4-osavuosiraportti
4.2.2026
Menneet tapahtumat
2025 Ylimääräinen yhtiökokous14.11.
2025 Q3-osavuosiraportti5.11.
2025 Q2-osavuosiraportti7.8.
2025 Q2-osavuosiraportti6.8.
2025 Q1-osavuosiraportti7.5.
Datan lähde: Millistream, Quartr

Tuotteita joiden kohde-etuutena tämä arvopaperi

3,75 DKK/osake
Viimeisin osinko
3,66 %Tuotto/v

Shareville

Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
  • 20 min sitten · Muokattu
    ·
    20 min sitten · Muokattu
    ·
    Lars Rebien Sørensen lifts the veil on a possible new strategy for the pharmaceutical giant. Here, he opened up the possibility that the pharmaceutical giant's popular GLP-1 medicine – including Wegovy and Ozempic – might in the future be sold as over-the-counter medicine. https://ekstrabladet.dk/penge/uden-recept-novo-konge-antyder-ny-kurs/11009971?utm_term=Autofeed&utm_medium=Social&utm_source=Facebook&fbclid=IwY2xjawOFRGxleHRuA2FlbQIxMABicmlkETAzRHhNQVZKWVg5Mmc0SE92c3J0YwZhcHBfaWQQMjIyMDM5MTc4ODIwMDg5MghjYWxsc2l0ZQEyAAEezBHDc0aZRfqSK-a_sMraT23t7nG5hEpmHkTrbbAglCZQt1XsINxZETG6pE0_aem_llU_Vg9ExjzAutNlb51DHw#Echobox=1763201526
  • 2 t sitten · Muokattu
    2 t sitten · Muokattu
    Can you feel it? Next week is going to be great! FOMO kicks in after this week's market pullback. People stock up on weight loss drugs to handle the Christmas feasts. Expectations of a pill approval is in the air (tempered by a bit of fears of FDA waiting for Eli to catch up). No explosions with no big good news but a nice green reinvestment week slowly seeing us try to break necklines. Have a nice weekend everyone!
  • 7 t sitten · Muokattu
    ·
    7 t sitten · Muokattu
    ·
    The stock is either consolidating or distributing around two important support lines. One is a multi-year trend back to 2017 and there is a support from 2021 before it took off. I want to see the stock break 314 before I can say that the damage is rectified after it has completed phase 4 in its cycle, and we go into phase 1 again. It is not entirely decided yet, we still don't know if phase 4 is finished, even though I personally believe it. It is not done overnight if anyone expects that. There is a lot of imbalance created in such a fall and it is completely normal to see a longer phase 1 form. Months are not uncommon.
    4 t sitten
    ·
    4 t sitten
    ·
    ....and Mars shall have an angle of 14.7 gr, to Jupiter..... Good weekend
    2 min sitten · Muokattu
    ·
    2 min sitten · Muokattu
    ·
    Typical statement, but I will answer briefly. TA can be used for a lot. I use it in short-term trading, to identify support, resistance, which indicates where buyers and sellers are. Impossible to trade without insight there. For investing, I use TA in a completely different way. I can use TA to identify the personality of the stock. For example, does it tend to hold 50 SMA, 200 SMA, and I can use that to get good entries. That can save me a ton of money compared to buying blindly. I also use TA to identify trends, where I use weekly and monthly trend indicators to identify bottoms and tops. Igjebflr good entries and exits. You don't use TA to identify value. That is fundamental analysis, which one should also do. One does fundamental analysis, macro analysis to identify the big picture. Then thinking to find entries. All stocks have personality, they very, very often repeat things they have done before in similar events. It's about identifying what history says about future behavior. And it works. You don't scan the market every second for that, you use long trends, weekly, monthly etc. The fact is that 80% of all market movements you see come from trading. That means that 80% of everyone is sitting and looking at exactly the same as you. That means a very high probability that something happens on these lines, as you call it. As long as you don't have or won't get into this, you will never understand it. Plain and simple. We others userservice for to create an Edge, to have a much higher degree of probability for an investment to be made in the right place. December 2021. I used long trends, and identified the fall in 2022, I did the same at the end of 2022 to identify that the trend was about to turn. That gave me unique opportunities. I took off a lot before 22, and put everything in at the end of the year ++++. I avoided sitting with dummy positions and seeing my stocks dumped 60/70%. You just have to calculate it if you avoided it on a million. Or five. Incredible that one can criticize something one knows nothing about is my message!!!! All large investors, institutions, banks' trading desks, hedge funds etc use this to gain an edge over the masses of small investors. I don't think they would have had thousands of traders working for fun. We start with fundamental and macro analysis to identify if a company is a good investment, then technical to find the best entry and exit. It all belongs together.
  • 13 t sitten
    ·
    13 t sitten
    ·
    It's a paradox that so many hate the NOVO stock due to self-ignorance, where one bought at 20x FPE and thought the stock was cheap. Also, when the price falls by 1/3, it was then actually "super expensive" and when FPE reaches 10 and dividend is around 5%, then it is again cheap, just much cheaper than before. Even if you made a good long-term investment that you are no longer as optimistic about, the "case" is relatively (EX competition and market development) the same even if the price is not. If you thought 500 DKK was a good price, then 350 is a fantastic price! The people here just lack some balls to stick with it or worse, they have FOMO because they are not surfing the AI wave, hahaha.
    32 min sitten
    ·
    32 min sitten
    ·
    There are/were many Novo shareholders who could just buy the stock and watch it rise. Thus, they could say they were “successful” investors. Unfortunately, they have had a rude awakening, and they face a dilemma: sell or hold. With a loss of 58% in the last year, it will take a long time to recover the loss. If it's even possible. At the same time, these same investors can look at the Eli Lilly stock with an increase of +38% in the last year. Or like my colleagues who use Rheinmetal as savings (they are a bit annoying to listen to🤣). It is immediately difficult to see what would make the Novo stock rise. There is uncertainty about management, future earnings, market shares, a thin short-term pipeline, U.S. sales, etc. Which is why many choose other growth stocks.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, ​​eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.

Tarjoustasot

DenmarkNasdaq Copenhagen
Määrä
Osto
1 871 502
Myynti
Määrä
1 794 608

Viimeisimmät kaupat

AikaHintaMääräOstajaMyyjä
43--
2 660--
109--
30--
61--
Ylin
314,95
VWAP
310,81
Alin
307,85
VaihtoMäärä
1 605,3 5 165 142
VWAP
310,81
Ylin
314,95
Alin
307,85
VaihtoMäärä
1 605,3 5 165 142

Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.

Välittäjätilasto

Dataa ei löytynyt